Whales with a lot of money to spend have taken a noticeably bullish stance on Procter & Gamble.
Looking at options history for Procter & Gamble (NYSE:PG) we detected 8 trades.
If we consider the specifics of each trade, it is accurate to state that 50% of the investors opened trades with bullish expectations and 50% with bearish.
From the overall spotted trades, 2 are puts, for a total amount of $166,750 and 6, calls, for a total amount of $496,473.
Predicted Price Range
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $145.0 to $185.0 for Procter & Gamble over the recent three months.
Insights into Volume & Open Interest
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Procter & Gamble's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Procter & Gamble's substantial trades, within a strike price spectrum from $145.0 to $185.0 over the preceding 30 days.
Procter & Gamble Option Activity Analysis: Last 30 Days
Biggest Options Spotted:
About Procter & Gamble
Procter & Gamble's Current Market Status
- Currently trading with a volume of 7,377,210, the PG's price is down by -0.26%, now at $173.77.
- RSI readings suggest the stock is currently may be approaching overbought.
- Anticipated earnings release is in 25 days.
What Analysts Are Saying About Procter & Gamble
In the last month, 2 experts released ratings on this stock with an average target price of $188.0.
Unusual Options Activity Detected: Smart Money on the Move
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Procter & Gamble options trades with real-time alerts from Benzinga Pro.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
